Norwalk, CTNCT04406831Now EnrollingIRB Ready

Pancreatic Cancer Stage III Clinical Trial in Norwalk, CT

Access cutting-edge pancreatic cancer stage iii treatment through this clinical trial at a research site in Norwalk. Study-provided care at no cost to qualified participants.

Sponsored by Nuvance Health

Quick Self-Assessment

See if you qualify for this Norwalk location

Preparing your pre-screening questions…

Expert Care in Norwalk

Access pancreatic cancer stage iii specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pancreatic cancer stage iii treatment provided free

Apply for This Norwalk Location

Check if you qualify for this pancreatic cancer stage iii clinical trial in Norwalk, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Norwalk

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Norwalk site if eligible
  4. 4Begin participation

About This Pancreatic Cancer Stage III Study in Norwalk

Aberrant miRNA production has been linked to a wide range of human cancers and shown to play important roles in their genesis and growth. These miRNA can be detected in the blood and tumors of patients with cancer. The investigators hypothesize that the detection of certain miRNAs present in the blood/serum of patients with pancreatic cancer may be important to the early diagnosis of the disease. Furthermore, the investigators hypothesize that miRNA detection in PC patients will yield prognostic information and help predict the response to treatment.

Sponsor: Nuvance Health

Who Can Participate

Inclusion Criteria

Have biopsy proven adenocarcinoma of the pancreas
Have initially inoperable disease, classified as either locally advanced or metastatic disease
Recurrent disease after a Whipple procedure is allowed
Patients who are able to undergo resection after neoadjuvant therapy will continue to be followed after resection
Have radiographically measurable disease
Have an ECOG performance status of 2 or less
Be willing to contribute the required information and specimens
Provide written signed consent to participate

Exclusion Criteria

Having received prior anti-cancer treatments for metastatic pancreatic cancer
Concurrently receiving systemic therapy for another cancer except androgen deprivation therapy for stable/controlled prostate cancer
Presence of other active cancer except for: adequately treated local basal or squamous cell carcinoma of the skin, cervical carcinoma in situ, superficial bladder cancer, asymptomatic prostate cancer without known metastatic disease and with no requirement for therapy or requiring only hormonal therapy and with normal prostate-specific antigen for \>1 year prior to start of trial. Other adequately treated Stage 1 or 2 cancer currently in complete remission, or any other cancer that has been in complete remission for \> 5 years is allowable

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Norwalk?

Yes, this clinical trial (NCT04406831) has an active research site in Norwalk, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pancreatic Cancer Stage III Treatment Options in Norwalk, CT

If you're searching for pancreatic cancer stage iii treatment options in Norwalk, CT, this clinical trial (NCT04406831) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Norwalk research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer stage iii specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pancreatic cancer stage iii clinical trials near you to find additional studies recruiting in your area.

More Pancreatic Cancer Trials in Norwalk, CT

See all pancreatic cancer clinical trials recruiting in Norwalk — not just this study.

Browse Pancreatic Cancer Trials in Norwalk →

Browse More Trials by Condition

Pancreatic Cancer TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Norwalk?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Norwalk, CT